Feltl & Co Downgrades Echo Therapeutics (ECTE) to Buy
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Price: $0.00 --0%
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE
Feltl & Co downgraded Echo Therapeutics (NASDAQ: ECTE) from Strong Buy to Buy with a price target of $2.35.
For an analyst ratings summary and ratings history on Echo Therapeutics click here. For more ratings news on Echo Therapeutics click here.
Shares of Echo Therapeutics closed at $1.85 yesterday.
For an analyst ratings summary and ratings history on Echo Therapeutics click here. For more ratings news on Echo Therapeutics click here.
Shares of Echo Therapeutics closed at $1.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
- Morgan Stanley Downgrades Peter Warren Automotive Holdings Ltd (PWR:AU) to Equalweight
- Barclays Downgrades Unite Group (UTG:LN) to Underweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
